VIP EARLY ALERT SERVICE Offered by Elite Traders Group for Limited Time, 20 Positions Remain. Only $29.95/Month or $199.00/Year
May 14 2013 - 8:30AM
InvestorsHub NewsWire
One of the most frequently asked questions is, "does your VIP group
receive alerts ahead of the crowd?" and the answer is YES. We offer
our VIP's early alerts and VIP only alerts that the rest of the
group is not privy to. VIP early alerts and VIP only alerts are
provided via our private VIP twitter feed which is not viewable by
the public. This allows us to keep VIP alerts within our exclusive
group and not accessible by third parties. Other VIP pre-promotion
alert services send by email which goes viral within minutes and
really is not a VIP alert at all. We typically send the new feature
alerts to our premium members 30 minutes to 24 hours in advance.
This gives our VIP's more time to conduct their due diligence and
avoid chasing the price action. Our group is growing at an
exponential rate and this service will be going up in price soon
and eventually closed for good. We currently have 80 VIP's
(verifiable at this twitter link: https://twitter.com/FPPVIP) and
will not exceed 100.
Use the following link now to increase your chances of success.
http://www.firstpennypicks.com/vip-membership/
Nuvilex, Inc. (OTCQB: NVLX) announced on Fri. May
10
th, 2013 that they are making "significant progress
toward the initiation of various cancer clinical trials, most
importantly the late-stage pancreatic cancer trial, given the
devastating and deadly nature of that disease."
NVLX is
utilizing live-cell encapsulation technology to treat pancreatic
cancer "which has demonstrated significant ability to activate the
cancer pro-drug ifosfamide in close proximity to the pancreatic
cancer itself." This technology is resulting in a high degree of
antitumor efficacy with a low toxicity profile in Phase II clinical
trials. To read more about the true potential of this technology
and price targets please use the following link:
http://www.firstpennypicks.com/fpps-complimentary-due-diligence-report/#DD
Solos Endoscopy, Inc. (OTCPINK: SNDY) continued its current
trend finishing the trading session on Fri. May 10
th,
2013 down 6.45%. The annual report issued on May 15
th,
2013 for the period ending Dec. 31
st, 2012 shows
increases in revenues and stockholders equity from the same period
in 2011. Despite these increases the PPS continues to fall after
hitting a 3 month high on Feb. 22
nd, 2013. To gain a
better understanding as to why the PPS continues to fall, use the
following link to view the full report:
http://www.firstpennypicks.com/fpps-complimentary-due-diligence-report/#DD
Lot78, Inc. (OTCQB: LOTE) has experienced a rapid increase
the PPS in the last 2 months.
LOTE is up over 1100% in this
very short term and at the close of trading on May 10
th,
2013 the stock was $11.00 a share. To learn receive a full report
and technical analysis please use the following link:
http://www.firstpennypicks.com/fpps-complimentary-due-diligence-report/#DD
Xumanii (OTCQB: XUII) is up over 75% as of mid-day on Mon.
May 13th, 2013. The stock has also traded over 162 M shares as of
that same time. This is brought on by heavy promotional activities
and is likely to continue this trend. To read the full report,
please use the following link:
http://www.firstpennypicks.com/fpps-complimentary-due-diligence-report/#DD
http://www.Firstpennypicks.com
was developed as a
beacon of hope in the micro-cap stock
newsletter industry. We always hand-pick our alerts as opposed to
biased advertising. Our service typically covers the hottest penny
stocks for a longer term than one day offering more potential
profit situations.
This is why we are the fastest growing
community of micro-cap traders on the web.
To Receive More Reports like this one Subscribe free at
http://www.FirstPennyPicks.com
For mobile alerts text "FPPALERTS" to 25827
Disclaimer: Firstpennypicks.com is owned by Elite traders Group
LLC. Information, opinions and analysis contained herein are based
on sources believed to be reliable, but no representation,
expressed or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only,
and is neither a solicitation to buy nor an offer to sell
securities. Certain information included herein is forward-looking
within the meaning of the Private Securities Litigation Reform Act
of 1995, including, but not limited to, statements concerning
manufacturing, marketing, growth, and expansion. Such
forward-looking information involves important risks and
uncertainties that could affect actual results and cause them to
differ materially from expectations expressed herein. First Penny
Picks has not been compensated for this report.
SOURCE: Elite Traders Group LLC
Contact: Editor@FirstPennyPicks.com